Global Medical REIT Files 8-K for Financial Results Disclosure

TL;DR

Global Medical REIT just filed an 8-K announcing it's reporting **financial results and statements** today, February 27, 2024.

AI Summary

Global Medical REIT Inc. filed an 8-K on February 27, 2024, to report its Results of Operations and Financial Condition, along with Financial Statements and Exhibits. This filing, identified by accession number 0001104659-24-028236, indicates the company is fulfilling its disclosure obligations under the Securities Exchange Act of 1934. The REIT, incorporated in Maryland, operates from its business address at 7373 Wisconsin Avenue, Suite 800, Bethesda, MD 20814.

Why It Matters

This filing signals that Global Medical REIT Inc. is making its latest financial performance and condition public, which is crucial for investors to assess the company's health and make informed decisions. The actual results, once released, will impact market perception and stock valuation.

Risk Assessment

Risk Level: low — The filing itself is a standard disclosure of intent to report financial results, not the results themselves, and thus carries low inherent risk.

Key Players & Entities

• Global Medical REIT Inc. (company) — Registrant and Filer
• February 27, 2024 (date) — Date of earliest event reported and filing date
• Maryland (company) — State of incorporation for Global Medical REIT Inc.
• 7373 Wisconsin Avenue, Suite 800, Bethesda, MD 20814 (company) — Business address of Global Medical REIT Inc.
• SCOOP MEDIA, INC. (company) — Former company name of the registrant

FAQ

Key Financial Figures

• $0.001 — h registered: Common Stock, par value $0.001 per share GMRE NYSE Series A Pref

Filing Documents

• tm247387d1_8k.htm (8-K) — 27KB
• tm247387d1_ex99-1.htm (EX-99.1) — 177KB
• tm247387d1_ex99-2.htm (EX-99.2) — 51KB
• logo.jpg (GRAPHIC) — 2KB
• tm247387d1_ex99-2pg001.jpg (GRAPHIC) — 146KB
• tm247387d1_ex99-2pg002.jpg (GRAPHIC) — 169KB
• tm247387d1_ex99-2pg003.jpg (GRAPHIC) — 132KB
• tm247387d1_ex99-2pg004.jpg (GRAPHIC) — 108KB
• tm247387d1_ex99-2pg005.jpg (GRAPHIC) — 152KB
• tm247387d1_ex99-2pg006.jpg (GRAPHIC) — 150KB
• tm247387d1_ex99-2pg007.jpg (GRAPHIC) — 184KB
• tm247387d1_ex99-2pg008.jpg (GRAPHIC) — 143KB
• tm247387d1_ex99-2pg009.jpg (GRAPHIC) — 152KB
• tm247387d1_ex99-2pg010.jpg (GRAPHIC) — 127KB
• tm247387d1_ex99-2pg011.jpg (GRAPHIC) — 148KB
• tm247387d1_ex99-2pg012.jpg (GRAPHIC) — 106KB
• tm247387d1_ex99-2pg013.jpg (GRAPHIC) — 168KB
• tm247387d1_ex99-2pg014.jpg (GRAPHIC) — 109KB
• tm247387d1_ex99-2pg015.jpg (GRAPHIC) — 182KB
• tm247387d1_ex99-2pg016.jpg (GRAPHIC) — 97KB
• tm247387d1_ex99-2pg017.jpg (GRAPHIC) — 105KB
• tm247387d1_ex99-2pg018.jpg (GRAPHIC) — 145KB
• tm247387d1_ex99-2pg019.jpg (GRAPHIC) — 141KB
• tm247387d1_ex99-2pg020.jpg (GRAPHIC) — 246KB
• tm247387d1_ex99-2pg021.jpg (GRAPHIC) — 226KB
• tm247387d1_ex99-2pg022.jpg (GRAPHIC) — 107KB
• 0001104659-24-028236.txt ( ) — 4980KB
• gmre-20240227.xsd (EX-101.SCH) — 3KB
• gmre-20240227_def.xml (EX-101.DEF) — 26KB
• gmre-20240227_lab.xml (EX-101.LAB) — 36KB
• gmre-20240227_pre.xml (EX-101.PRE) — 25KB
• tm247387d1_8k_htm.xml (XML) — 5KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On February 27, 2024, Global Medical REIT Inc. (the " Company ") announced its financial position as of December 31, 2023 and operating results for the three months and year ended December 31, 2023 and other related information (the " Earnings Release "). The Company also posted its Fourth Quarter 2023 Earnings Supplemental (the " Supplemental ") to the Company's website at www.globalmedicalreit.com. The Earnings Release and Supplemental are furnished as Exhibit 99.1 and Exhibit 99.2 , respectively, and are incorporated herein by reference. The information included in this Item 2.02 of this Current Report on Form 8-K, including the Earnings Release and Supplemental, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act ") or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Fourth Quarter and Year End 2023 Earnings Release. 99.2* Fourth Quarter and Year End 2023 Earnings Supplemental. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) *Furnished herewith

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Global Medical REIT Inc. By: /s/ Jamie A. Barber Jamie A. Barber Secretary and General Counsel Date: February 27, 2024

View Full Filing

View this 8-K filing on SEC EDGAR